# K071187: Microfuse Bone Void Filler

- Pathway: 510(k) (Traditional)
- Applicant: Globus Medical, Inc.
- Decided: Dec 20, 2007 after 234 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K960978 (1996). 20 ancestors in all.
4 later devices descend from it; 4 cite it directly.
0 of 25 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K012506: Mastergraft Resorbable Ceramic Granules, Medtronic Sofamor Danek USA, Inc. (2002) Summary page 1.
- K040047: Polygraft BGS; Bone Graft Substitute, Osteobiologics, Inc. (2004) Summary page 1.
- K060917: Kensey Nash Bone Void Filler, Kensey Nash Corporation (2006) Summary page 1.

## Most influential descendants
- K082442: Modification to Microfuse Bone Void Filler (2008), 2 descendants of its own
- K083232: Modification to:Microfuse Bone Void Filler (2008), 1 descendant of its own
- K102392: Microfuse Putty and Microfuse ST Mis (2010), 0 descendants of its own
- K083449: E-Matrix Graft Bone Extender (2009), 0 descendants of its own

## Indications for use
MicroFuse TM Bone Void Filler, combined with autograft or bone marrow aspirate, is intended for use in filling bony voids or gaps of the extremities and pelvis that are not intrinsic to the stability of the bony structure. These osseous defects may be surgically created or created from traumatic injury to the bone. MicroFuseTM provides a bone void filler that resorbs and is replaced with bone during the healing process.

Source page: https://510kreport.com/device/K071187
Methodology: https://510kreport.com/methodology